The partnership combines Qilu’s development and manufacturing capabilities with Cipla’s US commercial presence to expand access to affordable cancer therapies
Cipla’s US subsidiary partners with Qilu for Keytruda biosimilar
The partnership combines Qilu’s development and manufacturing capabilities with Cipla’s US commercial presence to expand access to affordable cancer t...
By Dhallo News · September 4, 2026 at 5:08 AM IST

Source: The Hindu BusinessLine - Companies
SOURCE: The Hindu BusinessLine - Companies
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion
